Aurinia Pharmaceuticals, Inc. (AUPH)
15.28
-0.56
(-3.54%)
USD |
NASDAQ |
May 15, 16:00
15.26
-0.02
(-0.10%)
Pre-Market: 20:00
Aurinia Pharmaceuticals Market Cap : 1.965B for May 15, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Xenon Pharmaceuticals, Inc. | 5.258B |
| Edesa Biotech, Inc. | 108.76M |
| ProMIS Neurosciences, Inc. | 22.36M |
| Medicus Pharma Ltd. | 16.60M |
| Kiniksa Pharmaceuticals International Plc | 4.348B |
Market Cap Related Metrics
| PE Ratio | 7.062 |
| PS Ratio | 7.035 |
| PEG Ratio | 0.0103 |
| Price to Book Value | 3.462 |
| Price to Free Cash Flow | 12.57 |
| Price | 15.28 |
| Earnings Yield | 14.16% |
| PEGY Ratio | 0.0103 |
| Operating PE Ratio | 16.14 |
| Normalized PE Ratio | 7.06 |